Stay updated with breaking news from Pranab Mody. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In December 2018, a consortium of growth-oriented private equity firms led by CX Partners acquired a 'significant' equity ownership in Veeda.
As per the latest Clinical Research Organisation (CLRO) Market Report by Frost & Sullivan (India), India is becoming an attractive destination for clinical and preclinical research outsourcing supported by quality scientific capability, the emergence of the biosimilars industry, increased demand for complex generics and availability of a large number of patient volunteers. A key player of the Indian CLRO market, Ahmedabad-based Veeda Clinical Research is all set to capitalise on the growing R&D budget of the global pharmaceutical firms. In conversation with BioSpectrum, Ajay Tandon, M...
We believe Veeda is well-positioned to capitalise on this opportunity as one of the largest independent full-service clinical research organisations, Sabres founder and managing partner Rajiv Maliwal said.The Ahmedabad-headquartered Sabre has invested USD 280 million in its nearly two-decade existence and returned USD 1.7 billion to investors from its three funds.